Register | Forgot password?
Switch to Arabic
Saturday, November 28 - 2009

DuBiotech to highlight latest advancements in life sciences at PABME 2008 in Dubai

  • United Arab Emirates: Thursday, April 24 - 2008 at 11:54
  • PRESS RELEASE

Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments and the leading business park dedicated to the global life science industry, today announced it will highlight the latest advancements in life sciences at the Pharmaceutical and Biotechnology Middle East 2008 (PABME), the first international exhibition and conference for the industry in the Middle East.

Article continues below
 
DuBiotech is a support sponsor of PABME 2008, which will be held from 27-29 April at the Dubai International Convention and Exhibition Centre. The event will bring together senior decision makers, scientists, and sales representatives from Europe, North and South America, Asia Pacific and the MENA regions.

Dr. Abdulqader Alkhayat, Executive Director, DuBiotech, said:

"PABME provides a unique platform for market leaders in the pharmaceutical and biotechnology sector to showcase their latest advancements. Its multi-track conferences will guarantee access to key international players, as well as offer avenues for exploring unprecedented business opportunities."


"DuBiotech's participation locks in with our mission to raise industry awareness, advance research and development initiatives, and encourage innovation in the region."

DuBiotech's business partners participating in the event will include Epygen Labs FZ LLC, Ergomed Clinical Research and Pharma Plan Middle East FZ LLC.

Global pharmaceuticals and biotechnology majors such as Pfizer recently joined DuBiotech's rapidly growing community. The presence of leading entities at DuBiotech is expected to add significant value to the biotechnology industry and contribute to its holistic development in the region.

Early this year, Dubiotech launched the Gulf Anti-doping and Monitoring Enterprise (GAME) as its subsidiary to conduct anti-doping tests on all professional and amateur athletes in the UAE. The life sciences park also launched the AED289 million Nucleotide Complex, the region's first dedicated modern laboratory compound to house a pre-clinical vivarium. Providing continuing education programmes, DuBiotech's newly established subsidiary - the BioTiqania Training Institute - provides world class courses in niche scientific and industrial disciplines.

In addition to pharmaceutical and biotechnology companies, DuBiotech aims to provide necessary infrastructure for all entities involved in the life sciences industry, including agricultural, environmental, and marine biotechnology sectors. The park also provides support services for R&D, manufacturing and commercial operations.

Offering a complete value chain to help companies set up operations, DuBiotech currently hosts 35 licensed firms. The free zone is working closely with the UAE Ministry of Health, the Dubai Health Authority, and other relevant regulatory bodies to further grow the life sciences industry in the country.
Also consider reading:
Log in to request more information from DuBiotech

Notes and media contacts

About DuBiotech
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is a science and business park dedicated to the biotechnology industry, set within a 'free zone'. DuBiotech has two arms. The first is the Foundation for Research and Innovation (FRI) that will initially focus on government-funded R&D in medicine and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with cutting-edge infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organizations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with global research leader, RTI International, DuBiotech is developing comprehensive regulations that address all aspects of biotech activity. Being in a 'free zone' means biotechnology firms in the park have 100 % exemption from any form of taxation for 50 years, 100 % business ownership and 100 % repatriation of capital.

For further information, please call:
Zeba Ahmad
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 361 3590 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001

OR

Cynthia Luna-Harb
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 375 5878 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions